The Benelux Racing League V6, better known as BRL V6, is a touring car racing series held in The Netherlands and Belgium between 2004 and 2009. It is the heavier variant on the BRL Light.
BRL-CAD is a constructive solid geometry (CSG) solid modeling computer-aided design (CAD) system. It includes an interactive geometry editor, ray tracing support for graphics rendering and geometric analysis, computer network distributed framebuffer support, scripting, image-processing and signal-processing tools.
BRL-52537 is a drug which acts as a potent and highly selective κ-opioid agonist. It has neuroprotective effects in animal studies, and is used for research into potential treatments for stroke and heart attack as well as more general brain research.
BRL-32872 is an experimental drug candidate that provides a novel approach to the treatment of cardiac arrhythmia.
BRL-50481 is a drug developed by GlaxoSmithKline which is the first compound that acts as a phosphodiesterase inhibitor selective for the PDE7 subtype.
BRL-44408 is a drug used in scientific research which acts as a selective antagonist for the α2A adrenoreceptor.
BRL-15,572 is a drug which acts as a selective antagonist for the serotonin receptor subtype 5-HT1D, with around 60x selectivity over other related receptors.
BRL-54443 is a drug which acts as a selective agonist for the 5-HT1E and 5-HT1F serotonin receptor subtypes.
Rosiglitazone (trade name Avandia, GlaxoSmithKline) is an antidiabetic drug in the thiazolidinedione class of drugs.
The BRLESC I (Ballistic Research Laboratories Electronic Scientific Computer) was a first-generation electronic computer built by the United States Army's Ballistic Research Laboratory (BRL) at Aberdeen Proving Ground with assistance from the National Bureau of Standards (now the National Institute of Standards and Technology), and was designed to take over the computational workload of EDVAC and ORDVAC, which themselves were successors of ENIAC.